Loading...
Market
What will be the impact on Humana's Medicare Part D market share by the end of 2024?
2
Resolution / Starting Odds
Increase by more than 5% • 25%
Decrease by more than 5% • 25%
Remain roughly the same • 25%
Other • 25%
Market analysis reports and news reports
Story
Humana to Pay $90 Million in Whistleblower Settlement
Aug 20, 2024, 01:49 PM
Humana has agreed to pay $90 million to the federal government to settle a whistleblower lawsuit. The suit, filed under the False Claims Act, alleged that Humana submitted fraudulent bids for Medicare Part D prescription drug contracts. The whistleblower, a former actuary of the company, accused the health insurer of overcharging the U.S. government for prescription drugs. The settlement concludes nearly two years of litigation.
View original story
Similar markets
Top 3 • 25%
Top 5 • 25%
Top 10 • 25%
Below Top 10 • 25%
0-10% • 25%
10-20% • 25%
20-30% • 25%
30% or more • 25%
Above $500 • 25%
Between $400 and $500 • 25%
Between $300 and $400 • 25%
Below $300 • 25%
Increase by > 5% • 25%
Increase by ≤ 5% • 25%
Decrease by ≤ 5% • 25%
Decrease by > 5% • 25%
Yes • 50%
No • 50%
UnitedHealth gains significant market share • 25%
Amedisys gains significant market share • 25%
Competitors gain significant market share • 25%
No significant change in market share • 25%
Above 75% • 25%
Between 50% and 75% • 25%
Between 25% and 50% • 25%
Below 25% • 25%
Less than 10% • 25%
10% - 20% • 25%
20% - 30% • 25%
More than 30% • 25%
Significant Increase • 25%
Significant Decrease • 25%
No Significant Change • 25%
Mixed Impact • 25%